The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Asenapine-Global Market Insights and Sales Trends 2024
Synopsis
Asenapine, sold under the trade names Saphris and Sycrest among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania
The global Asenapine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Asenapine in various end use industries. The expanding demands from the Children and Adult, are propelling Asenapine market. Patch, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sublingual Tablets segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Asenapine market, driven by demand from China, the second largest economy with some signs of stabilising, the Asenapine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Asenapine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Asenapine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Asenapine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Asenapine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Asenapine covered in this report include Merck, TargetMol, Actavis, Noven Pharmaceuticals and Lundbeck A / S, etc.
The global Asenapine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
TargetMol
Actavis
Noven Pharmaceuticals
Lundbeck A / S
Global Asenapine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Asenapine market, Segment by Type:
Patch
Sublingual Tablets
Global Asenapine market, by Application
Children
Adult
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Asenapine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Asenapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Asenapine, sold under the trade names Saphris and Sycrest among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania
The global Asenapine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Asenapine in various end use industries. The expanding demands from the Children and Adult, are propelling Asenapine market. Patch, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sublingual Tablets segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Asenapine market, driven by demand from China, the second largest economy with some signs of stabilising, the Asenapine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Asenapine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Asenapine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Asenapine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Asenapine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Asenapine covered in this report include Merck, TargetMol, Actavis, Noven Pharmaceuticals and Lundbeck A / S, etc.
The global Asenapine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
TargetMol
Actavis
Noven Pharmaceuticals
Lundbeck A / S
Global Asenapine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Asenapine market, Segment by Type:
Patch
Sublingual Tablets
Global Asenapine market, by Application
Children
Adult
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Asenapine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Asenapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Asenapine Market Overview
1.1 Asenapine Product Overview
1.2 Asenapine Market Segment by Type
1.2.1 Patch
1.2.2 Sublingual Tablets
1.3 Global Asenapine Market Size by Type
1.3.1 Global Asenapine Market Size Overview by Type (2018-2029)
1.3.2 Global Asenapine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Asenapine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Asenapine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Asenapine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Asenapine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Asenapine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Asenapine Sales Breakdown by Type (2018-2023)
2 Global Asenapine Market Competition by Company
2.1 Global Top Players by Asenapine Sales (2018-2023)
2.2 Global Top Players by Asenapine Revenue (2018-2023)
2.3 Global Top Players by Asenapine Price (2018-2023)
2.4 Global Top Manufacturers Asenapine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Asenapine Market Competitive Situation and Trends
2.5.1 Asenapine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Asenapine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asenapine as of 2022)
2.7 Date of Key Manufacturers Enter into Asenapine Market
2.8 Key Manufacturers Asenapine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Asenapine Status and Outlook by Region
3.1 Global Asenapine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Asenapine Historic Market Size by Region
3.2.1 Global Asenapine Sales in Volume by Region (2018-2023)
3.2.2 Global Asenapine Sales in Value by Region (2018-2023)
3.2.3 Global Asenapine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Asenapine Forecasted Market Size by Region
3.3.1 Global Asenapine Sales in Volume by Region (2024-2029)
3.3.2 Global Asenapine Sales in Value by Region (2024-2029)
3.3.3 Global Asenapine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Asenapine by Application
4.1 Asenapine Market Segment by Application
4.1.1 Children
4.1.2 Adult
4.2 Global Asenapine Market Size by Application
4.2.1 Global Asenapine Market Size Overview by Application (2018-2029)
4.2.2 Global Asenapine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Asenapine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Asenapine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Asenapine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Asenapine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Asenapine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Asenapine Sales Breakdown by Application (2018-2023)
5 North America Asenapine by Country
5.1 North America Asenapine Historic Market Size by Country
5.1.1 North America Asenapine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Asenapine Sales in Volume by Country (2018-2023)
5.1.3 North America Asenapine Sales in Value by Country (2018-2023)
5.2 North America Asenapine Forecasted Market Size by Country
5.2.1 North America Asenapine Sales in Volume by Country (2024-2029)
5.2.2 North America Asenapine Sales in Value by Country (2024-2029)
6 Europe Asenapine by Country
6.1 Europe Asenapine Historic Market Size by Country
6.1.1 Europe Asenapine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Asenapine Sales in Volume by Country (2018-2023)
6.1.3 Europe Asenapine Sales in Value by Country (2018-2023)
6.2 Europe Asenapine Forecasted Market Size by Country
6.2.1 Europe Asenapine Sales in Volume by Country (2024-2029)
6.2.2 Europe Asenapine Sales in Value by Country (2024-2029)
7 Asia-Pacific Asenapine by Region
7.1 Asia-Pacific Asenapine Historic Market Size by Region
7.1.1 Asia-Pacific Asenapine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Asenapine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Asenapine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Asenapine Forecasted Market Size by Region
7.2.1 Asia-Pacific Asenapine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Asenapine Sales in Value by Region (2024-2029)
8 Latin America Asenapine by Country
8.1 Latin America Asenapine Historic Market Size by Country
8.1.1 Latin America Asenapine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Asenapine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Asenapine Sales in Value by Country (2018-2023)
8.2 Latin America Asenapine Forecasted Market Size by Country
8.2.1 Latin America Asenapine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Asenapine Sales in Value by Country (2024-2029)
9 Middle East and Africa Asenapine by Country
9.1 Middle East and Africa Asenapine Historic Market Size by Country
9.1.1 Middle East and Africa Asenapine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Asenapine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Asenapine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Asenapine Forecasted Market Size by Country
9.2.1 Middle East and Africa Asenapine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Asenapine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Asenapine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Asenapine Products Offered
10.1.5 Merck Recent Development
10.2 TargetMol
10.2.1 TargetMol Company Information
10.2.2 TargetMol Introduction and Business Overview
10.2.3 TargetMol Asenapine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 TargetMol Asenapine Products Offered
10.2.5 TargetMol Recent Development
10.3 Actavis
10.3.1 Actavis Company Information
10.3.2 Actavis Introduction and Business Overview
10.3.3 Actavis Asenapine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Actavis Asenapine Products Offered
10.3.5 Actavis Recent Development
10.4 Noven Pharmaceuticals
10.4.1 Noven Pharmaceuticals Company Information
10.4.2 Noven Pharmaceuticals Introduction and Business Overview
10.4.3 Noven Pharmaceuticals Asenapine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Noven Pharmaceuticals Asenapine Products Offered
10.4.5 Noven Pharmaceuticals Recent Development
10.5 Lundbeck A / S
10.5.1 Lundbeck A / S Company Information
10.5.2 Lundbeck A / S Introduction and Business Overview
10.5.3 Lundbeck A / S Asenapine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Lundbeck A / S Asenapine Products Offered
10.5.5 Lundbeck A / S Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Asenapine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Asenapine Industrial Chain Analysis
11.4 Asenapine Market Dynamics
11.4.1 Asenapine Industry Trends
11.4.2 Asenapine Market Drivers
11.4.3 Asenapine Market Challenges
11.4.4 Asenapine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Asenapine Distributors
12.3 Asenapine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
